EDCTP
Sponsor: European and Developing Countries Clinical Trials Partnership (EDCTP)
(Principal Investigator - Harriet Mayanja-Kizza, MBChB, MMed, Uganda)
Type of Study / Description |
The evaluation of Mycobacterium tuberculosis specific host cytokine signatures in whole blood culture supernatants as diagnostic biomarkers for active TB infection |
Interactions With TBRU |
Collaborating investigators/staff, utilizing shared infrastructure.
|
Overview of EDCTP
EDCTP is a partnership of 14 European Union countries, Switzerland and Norway, and 47 sub-Saharan African countries, which aims to establish a research and development programme for the development of new or improved clinical interventions to combat HIV/AIDS, tuberculosis and malaria through a long-term partnership between Europe and sub-Saharan Africa. EDCTP will primarily aim to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria, with focus on phase II and III clinical trials in sub-Saharan Africa. The main objectives are:
- Acceleration of the development of new or improved clinical interventions, in particular drugs, microbicides and vaccines to fight HIV/AIDS, tuberculosis and malaria in sub-Saharan Africa through conducting and supporting clinical trials especially phases II and III
- Increasing African research capacity to tackle these diseases
- Supporting and facilitating the integration of the national health research programmes of the European Member States
- Strengthening of the related research and development capacity in sub-Saharan Africa. This includes fostering an enabling environment for best practice, including capacity development for Good Clinical Practice (GCP), sound ethical review and a strong regulatory framework.
For further information about EDCTP, visit the website: http://www.edctp.org/Home.162.0.html
|
